MedPath

Diclofenac Potassium

DICLOFENAC POTASSIUM TABLETS USP, 50 mg Rx only

Approved
Approval ID

0d83cab3-c698-4763-9e77-27d72ba94e30

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2023

Manufacturers
FDA

Archis Pharma LLC

DUNS: 026836212

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diclofenac potassium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72819-151
Application NumberANDA075463
Product Classification
M
Marketing Category
C73584
G
Generic Name
diclofenac potassium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (12)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYDEXTROSEInactive
Code: VH2XOU12IE
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
DICLOFENAC POTASSIUMActive
Quantity: 50 mg in 1 1
Code: L4D5UA6CB4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.